{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "Aspirin",
            "via": [],
            "to": "Hereditary haemorrhagic telangiectasia",
            "success_criteria": "需要补充对 Aspirin 不良反应机制的解释",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "Warfarin",
            "via": [],
            "to": "Hereditary haemorrhagic telangiectasia",
            "success_criteria": "需要补充对 Warfarin 不良反应机制的解释",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "Clopidogrel",
            "via": [],
            "to": "Hereditary haemorrhagic telangiectasia",
            "success_criteria": "需要补充对 Clopidogrel 不良反应机制的解释",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_warfarin",
          "type": "Drug",
          "label": "Warfarin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_clopidogrel",
          "type": "Drug",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_heparin",
          "type": "Drug",
          "label": "Heparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nsaid",
          "type": "Drug",
          "label": "Nonsteroidal anti-inflammatory drugs",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thrombolytics",
          "type": "Drug",
          "label": "Thrombolytics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rivaroxaban",
          "type": "Drug",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dabigatran",
          "type": "Drug",
          "label": "Dabigatran",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apixaban",
          "type": "Drug",
          "label": "Apixaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ticlopidine",
          "type": "Drug",
          "label": "Ticlopidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dipyridamole",
          "type": "Drug",
          "label": "Dipyridamole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_coxibs",
          "type": "Drug",
          "label": "Coxibs",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_hht",
          "type": "Disease",
          "label": "Hereditary haemorrhagic telangiectasia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_aspirin",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知与出血风险相关"
        },
        {
          "source": "n_warfarin",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "用于抗凝，出血风险高"
        },
        {
          "source": "n_clopidogrel",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "类聚集抑制作用，可能导致出血"
        },
        {
          "source": "n_heparin",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗凝效应，相关出血风险"
        },
        {
          "source": "n_nsaid",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常见出血风险提示"
        },
        {
          "source": "n_thrombolytics",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "增加出血风险"
        },
        {
          "source": "n_rivaroxaban",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "属于抗凝剂，出血风险"
        },
        {
          "source": "n_dabigatran",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "抗凝性质，风险增加"
        },
        {
          "source": "n_apixaban",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "抗凝作用相关"
        },
        {
          "source": "n_ticlopidine",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能引起出血风险"
        },
        {
          "source": "n_dipyridamole",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "增大出血风险"
        },
        {
          "source": "n_coxibs",
          "target": "n_hht",
          "relation": "contraindicates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "NSAID类药物相关风险"
        }
      ],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "skipped",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": []
        },
        "notes": "与支持性目标不符或信息不足"
      },
      {
        "action_ref": 1,
        "status": "skipped",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": []
        },
        "notes": "与支持性目标不符或信息不足"
      },
      {
        "action_ref": 2,
        "status": "skipped",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": []
        },
        "notes": "与支持性目标不符或信息不足"
      }
    ],
    "unexecuted_actions": [
      {
        "action_ref": 0,
        "status": "skipped",
        "reason": "未能提供对 Aspirin 不良反应机制的解释"
      },
      {
        "action_ref": 1,
        "status": "skipped",
        "reason": "未能提供对 Warfarin 不良反应机制的解释"
      },
      {
        "action_ref": 2,
        "status": "skipped",
        "reason": "未能提供对 Clopidogrel 不良反应机制的解释"
      }
    ],
    "residual_gaps": [
      "缺少对这些药物的详细机制解释以理解其与遗传性出血性毛细血管扩张的相关性。"
    ]
  }
}